D-0977-2017 Class II Terminated

Recalled by SCA Pharmaceuticals — Little Rock, AR

FDA drug recall D-0977-2017 was initiated by SCA Pharmaceuticals on June 21, 2017 and is designated Class II. Reason for recall: Lack of sterility assurance The recall status is terminated (terminated April 3, 2019). Affected quantity: 660 bags.

Recall Details

Product Type
Drugs
Report Date
July 19, 2017
Initiation Date
June 21, 2017
Termination Date
April 3, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
660 bags

Product Description

Potassium PHOSphate added to 250 mL 0.9% Sodium Chloride 15 mMol (22 mEq K+) Total Approximate Volume 255 mL, Rx only, SCA Pharmaceuticals, Little Rock, AR 72205, NDC 70004-0841-40

Reason for Recall

Lack of sterility assurance

Distribution Pattern

LA, PA, NY, WI

Code Information

Lot #: 20170509@6, Exp 6/23/2017; 20170519@35, Exp 7/3/2017; 20170523@22, Exp 7/7/2017; 20170525@9, Exp 7/9/2017; 20170605@49, Exp 7/20/2017; 20170605@9, Exp 7/20/2017